These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17599040)

  • 41. SMC4 knockdown inhibits malignant biological behaviors of endometrial cancer cells by regulation of FoxO1 activity.
    Yan Y; Liu C; Zhang J; Li W; Yin X; Dong L; Pang S; Li X
    Arch Biochem Biophys; 2021 Nov; 712():109026. PubMed ID: 34506757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.
    Tong H; Ke JQ; Jiang FZ; Wang XJ; Wang FY; Li YR; Lu W; Wan XP
    Cancer Lett; 2016 Jun; 376(1):127-36. PubMed ID: 27018308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long noncoding RNA LINC00261 regulates endometrial carcinoma progression by modulating miRNA/FOXO1 expression.
    Fang Q; Sang L; Du S
    Cell Biochem Funct; 2018 Aug; 36(6):323-330. PubMed ID: 30019459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
    Romero-Pérez L; Castilla MÁ; López-García MÁ; Díaz-Martín J; Biscuola M; Ramiro-Fuentes S; Oliva E; Matias-Guiu X; Prat J; Cano A; Moreno-Bueno G; Palacios J
    Hum Pathol; 2013 Feb; 44(2):244-54. PubMed ID: 22974476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
    Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of tgfb1 protein in endometrioid adenocarcinoma.
    Soufla G; Sifakis S; Porichis F; Spandidos DA
    Eur J Clin Invest; 2013 Jan; 43(1):79-90. PubMed ID: 23176363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.
    Yanokura M; Banno K; Susumu N; Kawaguchi M; Kuwabara Y; Tsukazaki K; Aoki D
    Anticancer Res; 2006; 26(2A):851-6. PubMed ID: 16619479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and clinical significance of KDM5A, KDM5B, and FOXO1 in endometrial cancer.
    Gao Y; Gao J
    Pol J Pathol; 2024; 75(2):83-96. PubMed ID: 39166517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
    Hevir-Kene N; Rižner TL
    Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.
    Zhang Z; Dong L; Sui L; Yang Y; Liu X; Yu Y; Zhu Y; Feng Y
    Int J Gynecol Cancer; 2011 Feb; 21(2):213-21. PubMed ID: 21270604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. G-protein coupled receptor 64 (GPR64) acts as a tumor suppressor in endometrial cancer.
    Ahn JI; Yoo JY; Kim TH; Kim YI; Broaddus RR; Ahn JY; Lim JM; Jeong JW
    BMC Cancer; 2019 Aug; 19(1):810. PubMed ID: 31412816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lnc-NA inhibits proliferation and metastasis in endometrioid endometrial carcinoma through regulation of NR4A1.
    Sun L; Zhou R; Dong J; Liu S; Jiao Y; Wang L; Hu S; He P; Liu X; Zhao X; Jiang G; Zhao Y
    J Cell Mol Med; 2019 Jul; 23(7):4699-4710. PubMed ID: 31050196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of FOXO1A in the regulation of insulin-like growth factor-binding protein-1 in human endometrial cells: interaction with progesterone receptor.
    Kim JJ; Buzzio OL; Li S; Lu Z
    Biol Reprod; 2005 Oct; 73(4):833-9. PubMed ID: 15987820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of forkhead box C2 on carcinogenesis and lymphatic metastasis in endometrial carcinoma.
    Fan YY; Deng WG; Liu YN; Li YY; Deng SL; Fu Y
    Genet Mol Res; 2015 May; 14(2):5535-47. PubMed ID: 26125751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of Hedgehog Signals and Growth Inhibition by Itraconazole in Endometrial Cancer.
    Inoue K; Tsubamoto H; Sakata K; Sakane R; Hao H; Hirota S; Sonoda T; Shibahara H
    Anticancer Res; 2016 Jan; 36(1):149-53. PubMed ID: 26722038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
    Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
    Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.
    Li Q; Qiu XM; Li QH; Wang XY; Li L; Xu M; Dong M; Xiao YB
    Oncol Rep; 2015 May; 33(5):2354-60. PubMed ID: 25708247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells.
    Byron SA; Loch DC; Pollock PM
    Int J Gynecol Cancer; 2012 Nov; 22(9):1517-26. PubMed ID: 23060048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.